Status:
COMPLETED
Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
Lead Sponsor:
Henry Ford Health System
Conditions:
Anterior Cruciate Ligament Injury
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of anterior cruciate ligamen...
Detailed Description
Study Design: This is a randomized, single blinded, standard of care-controlled clinical trial. All adult patients over eighteen desiring anterior cruciate ligament reconstruction will be eligible. No...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- All adult patients over age 18 and scheduled for a primary or revision anterior cruciate ligament reconstruction
Exclusion
- Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact anterior cruciate ligament reconstruction
Key Trial Info
Start Date :
January 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2020
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03818932
Start Date
January 22 2019
End Date
May 20 2020
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202